TOKYO, May 13 (Reuters) - Astellas Pharma Inc, Japan’s second-largest drugmaker, forecast on Wednesday a second straight year of profit falls, hurt by a stronger yen and higher costs to beef up its product pipeline.
TOKYO, May 13 (Reuters) - Astellas Pharma Inc, Japan’s second-largest drugmaker, forecast on Wednesday a second straight year of profit falls, hurt by a stronger yen and higher costs to beef up its product pipeline.
